Æona: Pioneering Biopharmaceutical Innovation with humanized Antibody Discovery + AI-Enhanced Optimization and Rational Data-driven Engineering
Discover how Æona, a biopharmaceutical trailblazer, leverages Artificial Intelligence and cutting-edge technology to revolutionize drug development, offering new hope to patients worldwide.
At Aeona Pharma, our core mission is to bring cutting-edge pharmaceutical solutions to the market and enhance the quality of life for patients worldwide.
Æona is confident that our advanced drug discovery and AI-enhanced antibody engineering will spearhead a new revolution in the field of antibody therapeutics. Our commitment extends to developing new treatments that hold the promise of transforming the lives of countless individuals. We share a visionary mission with our partners, united in the pursuit of making a profound difference in healthcare and pioneering a brighter, healthier future for all.
We are committed to pushing the boundaries of drug development by embracing innovation and collaboration to ensure that the treatments we create make a meaningful impact.
Our cutting-edge Artificial Intelligence (AI)-driven antibody engineering platform redefines the boundaries of computational protein design. Through the power of in-house trained AI, we've unlocked the potential to optimize protein properties via in silico screening of up to 10^25 variants. This groundbreaking approach empowers us to explore a significantly wider spectrum of potential drug candidates, transcending the limitations of traditional laboratories that typically manage numbers closer to 10^10. The result? An accelerated drug development process that widens the realm of possibilities for patients actively seeking new and effective treatments.
Join us at Æona as we embark on an exciting journey towards redefining the biopharmaceutical landscape. Our AI-driven innovations in antibody engineering offer new hope and endless possibilities for patients worldwide, p
Company Details
- Founded
- -
- Address
- San Diego, Ca 92109-2519, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.aeonapharma.com/
- Keywords
- drug development, oncology, antibody engineering, artificial intelligence, machine learning, humanized antibody discovery, Partnership, Collaboration, Pharmaceutical Licensing, Intellectual Property.
- HQ
- San Diego, CA
- Competitors
- Interactive Medical Technologies (IMT Labs) - a Division of Stason Pharmaceuticals, Leading Edge Bio, Thesan Pharmaceuticals, Tempo Bioscience, Imyun Pharmaceuticals, Tivorsan Pharmaceuticals, Erimos Pharmaceuticals LLC, Refactor BioSciences, Wallace Pharmaceuticals, AbCura Pharmaceuticals.
Aeona Pharmaceuticals Questions
Aeona Pharmaceuticals's website is https://www.aeonapharma.com/
Aeona Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/aeonapharma
Aeona Pharmaceuticals's industry is
Biotechnology Research
Aeona Pharmaceuticals's top competitors are
Interactive Medical Technologies (Imt Labs) - A Division Of Stason Pharmaceuticals,
Leading Edge Bio,
Thesan Pharmaceuticals,
Tempo Bioscience,
Imyun Pharmaceuticals,
Tivorsan Pharmaceuticals,
Erimos Pharmaceuticals Llc,
Refactor Biosciences,
Wallace Pharmaceuticals,
Abcura Pharmaceuticals.
Aeona Pharmaceuticals's categories are Biotechnology Research
Aeona Pharmaceuticals's founding year is 2023
